TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9884249

Group type: EXPERIMENTAL
Intervention: C2 (700-1000 ng/ml)
Number of subjects: 35

Group type: COMPARATOR
Intervention: C0 (100-200 ng/ml)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: C2 (300-600 ng/ml)
Number of subjects: 35
Study: 8571773

Group type: EXPERIMENTAL
Intervention: Subcuticular suture using absorbable material (Dexon)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Continuous transdermal blanket suture using nonabsorbable material (silk)
Number of subjects: 80
Study: 1535202

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia (2.5 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thiamylal-enflurane anesthesia (4 mg/kg)
Number of subjects: 60
Study: 6498579

Group type: EXPERIMENTAL
Intervention: Propranolol 0.01 mg X kg‐1 IV, administered two minutes prior to induction
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propranolol 0.01 mg X kg‐1 IV, administered five minutes prior to induction
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propranolol 0.01 mg X kg‐1 IV, administered eight minutes prior to induction
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline pretreatment, administered five minutes prior to induction
Number of subjects: 40
Study: 31357408

Group type: EXPERIMENTAL
Intervention: Education-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30012178

Group type: EXPERIMENTAL
Intervention: LigaSure™
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: HARMONIC ACE®+7
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard surgical techniques (titanium clips and conventional knot-tying ligations)
Number of subjects: 69
Study: 26861957

Group type: EXPERIMENTAL
Intervention: Photo-activated platelet-rich plasma (PA-PRP)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 37
Study: 25936814

Group type: EXPERIMENTAL
Intervention: Radiation therapy (total dose of 6.0 Gy applied in 6 fractions of 1.0 Gy three times a week)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Local corticosteroid injections (1 ml injection of 40 mg methylprednisolone and 0.5 ml 1% lidocaine under the guidance of palpation)
Number of subjects: 128
Study: 23566060

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (30 g/day) for 30 days
Number of subjects: 147
Study: 20623950

Group type: EXPERIMENTAL
Intervention: Detailed scoring system of diagnostics of GBC
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Diminished scoring system of diagnostics of GBC
Number of subjects: 124
Study: 18156147

Group type: EXPERIMENTAL
Intervention: Comprehensive school‐randomized fruit and vegetable intervention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16491348

Group type: EXPERIMENTAL
Intervention: Gastrografin (350 ml) of three different concentrations
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Mannitol, iohexol, or iodixanol with equivalent osmolarities
Number of subjects: 4

Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 4
Study: 14684757

Group type: EXPERIMENTAL
Intervention: 8 fl. oz. orange juice
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 16 fl. oz. orange juice
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Supplemental vitamin C (approximately 70 mg/day)
Number of subjects: 11
Study: 10947757

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 40
Study: 9233735

Group type: EXPERIMENTAL
Intervention: rhIL‐1ra (100 mg) followed by a 72‐hr continuous intravenous infusion of rhIL‐1ra (2.0 mg/kg/hr)
Number of subjects: 696

Group type: COMPARATOR
Intervention: Placebo (vehicle) followed by a 72‐hr continuous intravenous infusion of placebo
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: rhIL‐1ra
Number of subjects: 696

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 696
Study: 8497364

Group type: EXPERIMENTAL
Intervention: 0.75% metronidazole vaginal gel
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Crossover to metronidazole gel
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Metronidazole gel
Number of subjects: 53
Study: 3305215

Group type: EXPERIMENTAL
Intervention: Modified BFM protocol
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Modified BFM protocol (SR group)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Modified BFM protocol (HR group)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: 18-month maintenance therapy
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Intermediate-dose methotrexate (IDMTX) plus intrathecal methotrexate
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Irradiation plus intrathecal methotrexate
Number of subjects: 382
Study: 29476019

Group type: EXPERIMENTAL
Intervention: 10 mg/kg fresolimumab
Number of subjects: 23

Group type: COMPARATOR
Intervention: 1 mg/kg fresolimumab
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Focal radiotherapy (three doses of 7.5 Gy)
Number of subjects: 23
Study: 26622051

Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone (250 mg) every 2 weeks for 24 weeks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (1 mL saline) every 2 weeks for 24 weeks
Number of subjects: 94
Study: 24605710

Group type: EXPERIMENTAL
Intervention: Radiofrequency and lateral displacement of the inferior turbinate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Radiofrequency alone
Number of subjects: 60
Study: 21862223

Group type: EXPERIMENTAL
Intervention: 24 IU intranasal oxytocin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 19949163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 18274461

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 30
Study: 16222197

Group type: EXPERIMENTAL
Intervention: Terbinafine 625 mg/day (n = 25)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (n = 28)
Number of subjects: 53
Study: 11906981

Group type: EXPERIMENTAL
Intervention: Guided Disclosure Protocol (GDP) group (n = 22)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 41
Study: 10150266

Group type: EXPERIMENTAL
Intervention: MS Contin 30 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MS Contin 60 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oramorph SR 60 mg
Number of subjects: 100
Study: 3122699

Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride (dosage not specified)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Plasma metabolite concentrations
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Plasma HB levels
Number of subjects: 12
Study: 31505892

Group type: EXPERIMENTAL
Intervention: Pattern Management (PM) education using continuous glucose monitoring system (CGMS) results
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional diabetes education (Control)
Number of subjects: 0
Study: 28590765

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional treatment (rest, NSAİİ, bracing, exercise)
Number of subjects: 41
Study: 26254125

Group type: EXPERIMENTAL
Intervention: Blue light exposure during acute hypoxia
Number of subjects: 57

Group type: COMPARATOR
Intervention: Common artificial light exposure during acute hypoxia
Number of subjects: 57
Study: 23163825

Group type: EXPERIMENTAL
Intervention: Losartan 200 mg/day
Number of subjects: 13

Group type: COMPARATOR
Intervention: Losartan 50 mg/day
Number of subjects: 13
Study: 20817148

Group type: EXPERIMENTAL
Intervention: Group Person-Based Cognitive Therapy (PBCT)
Number of subjects: 62
Study: 19366676

Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 16679299

Group type: EXPERIMENTAL
Intervention: Lercanidipine 10-20 mg once daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Losartan 50-100 mg once daily
Number of subjects: 26
Study: 15572814

Group type: EXPERIMENTAL
Intervention: Penicillin G + Chloramphenicol (n:46)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (n:51)
Number of subjects: 97
Study: 11734580

Group type: EXPERIMENTAL
Intervention: Walnut-enriched diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 10
Study: 9204351

Group type: EXPERIMENTAL
Intervention: iopentol 300 mg I/ml
Number of subjects: 518

Group type: COMPARATOR
Intervention: iopromide 300 mg I/ml
Number of subjects: 518
Study: 8215565

Group type: EXPERIMENTAL
Intervention: Early lipid containing parenteral nutrition
Number of subjects: 129

Group type: COMPARATOR
Intervention: Late lipid containing parenteral nutrition
Number of subjects: 129
Study: 3379988

Group type: EXPERIMENTAL
Intervention: Respiratory home care (RHC)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Standard home care (SHC)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Office care (OC)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: All groups (RHC, SHC, OC)
Number of subjects: 301
Study: 31763749

Group type: EXPERIMENTAL
Intervention: PINC parent-training program
Number of subjects: 57
Study: 31280594

Group type: EXPERIMENTAL
Intervention: Cuff pressure monitoring
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Cuff pressure measurement at induction
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Cuff pressure aim for supraglottic airway devices
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Cuff pressure aim for endotracheal tubes
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Access to cuff pressure manometer
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Desire for cuff pressure manometer
Number of subjects: 305
Study: 28985195

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.1 mg/kg IV bolus 10 hours before surgery)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 161
Study: 25765602

Group type: EXPERIMENTAL
Intervention: Constraint‐Induced Aphasia Therapy (CIAT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Semantic therapy (BOX)
Number of subjects: 9
Study: 23468874

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 (10^8 cfu)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 22064013

Group type: EXPERIMENTAL
Intervention: Six hour simulation-based programme in care of a patient with physiological deterioration
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 31
Study: 19204212

Group type: EXPERIMENTAL
Intervention: GP training plus cost-free nicotine replacement medication and/or bupropion hydrochloride
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: GP training plus GP remuneration for each abstinent patient
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Combination of GP training plus GP remuneration and cost-free nicotine replacement medication and/or bupropion hydrochloride
Number of subjects: 577

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 577
Study: 17322142

Group type: EXPERIMENTAL
Intervention: Anidulafungin (200 mg IV on day 4, followed by 100 mg IV on days 5-13)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tacrolimus (5 mg orally on days 1 and 13)
Number of subjects: 20
Study: 15068946

Group type: EXPERIMENTAL
Intervention: Protocol A (80 kV, 135 mAs)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Protocol B (80 kV, 180 mAs)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Standard protocol (120 kV, 90 mAs)
Number of subjects: 142
Study: 11450875

Group type: EXPERIMENTAL
Intervention: Simulated fire-fighting tasks (boundary cooling, drum carry, extinguisher carry, hose run, ladder climb)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Simulated fire-fighting tasks
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Simulated fire-fighting tasks with SCBA
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: VO2max recommendation
Number of subjects: 49
Study: 9806253

Group type: EXPERIMENTAL
Intervention: GnRHa (nafarelin acetate/Synarel) at a dosage of 200 microg three times daily until HCG administration
Number of subjects: 64

Group type: COMPARATOR
Intervention: GnRHa (nafarelin acetate/Synarel) reduced to 200 microg twice daily as ovarian stimulation was initiated
Number of subjects: 64
Study: 9050471

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted vaginal hysterectomy with bilateral salpingo-oophorectomy (LAVH-BSO)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy with bilateral salpingo-oophorectomy (TAH-BSO)
Number of subjects: 40
Study: 3347522

Group type: EXPERIMENTAL
Intervention: Cephalocaudal stroking procedure
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Multisensory hammock with auditory, vestibular, and tactile stimulation
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Combination of cephalocaudal stroking and multisensory hammock
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (natural stimulation in home environments)
Number of subjects: 81
Study: 29795368

Group type: EXPERIMENTAL
Intervention: Plant sterols (PS) 2 g/d
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control (low-fat spreads without added PS)
Number of subjects: 161
Study: 29122147

Group type: EXPERIMENTAL
Intervention: Standard cardiac rehabilitation (CR) with stress management training (SMT)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard cardiac rehabilitation (CR) without stress management training (SMT)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Higher levels of physical activity (PA)
Number of subjects: 119
Study: 26790552

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 120
Study: 23731717

Group type: EXPERIMENTAL
Intervention: Extraction of pulpally involved teeth
Number of subjects: 145
Study: 21187254

Group type: EXPERIMENTAL
Intervention: Nurse-led nonpharmacologic intervention (4 home visits by a nurse)
Number of subjects: 349

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 349
Study: 18441530

Group type: EXPERIMENTAL
Intervention: Combined HB‐Hib vaccine (Hebervac HB‐Hib)
Number of subjects: 25

Group type: COMPARATOR
Intervention: HB vaccine (Heberbiovac‐HB) and Hib vaccine (QuimiHib)
Number of subjects: 25
Study: 16569462

Group type: EXPERIMENTAL
Intervention: Maintenance gemcitabine (1,250 mg/m² on days 1 and 8 every 21 days) plus best supportive care (GEM arm)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Best supportive care only (BSC arm)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Maintenance gemcitabine (GEM arm)
Number of subjects: 352
Study: 12714194

Group type: EXPERIMENTAL
Intervention: Chemical cardioversion
Number of subjects: 139

Group type: COMPARATOR
Intervention: Electrical cardioversion
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs
Number of subjects: 139

Group type: COMPARATOR
Intervention: Electrical procedure
Number of subjects: 139
Study: 10934454

Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 16

Group type: COMPARATOR
Intervention: Soluble human insulin
Number of subjects: 16
Study: 8737166

Group type: COMPARATOR
Intervention: 0 MJ preload
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 1.26 MJ preload
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 2.51 MJ preload
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 250 g preload
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 500 g preload
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 750 g preload
Number of subjects: 37
Study: 1559192

Group type: EXPERIMENTAL
Intervention: Quinapril (2.5, 5, 10 or 20 mg bid for four weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (for four weeks prior to quinapril therapy)
Number of subjects: 25
Study: 3926036

Group type: EXPERIMENTAL
Intervention: Low residue liquidized diet (Isocal) administered to treatment group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine intravenous therapy administered to control group
Number of subjects: 50
Study: 31672256

Group type: EXPERIMENTAL
Intervention: Visco-ease™ oral spray
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 30598489

Group type: EXPERIMENTAL
Intervention: Guided internet-based intervention (iSOMA) for 8 weeks
Number of subjects: 154

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 154
Study: 27788851

Group type: EXPERIMENTAL
Intervention: Hybrid algorithm for CTO-PCI
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Antegrade wire escalation
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Consecutive strategies
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Antegrade dissection re-entry
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Retrograde strategies
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Procedure time
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Fluoroscopy time
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Contrast volume
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Radiation doses
Number of subjects: 1177
Study: 24063767

Group type: EXPERIMENTAL
Intervention: EPA plus DHA supplementation (0, 1, 2 or 4 portions of oily fish per week for 12 months)
Number of subjects: 0
Study: 22541039

Group type: EXPERIMENTAL
Intervention: Treatment (specific treatment not detailed)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Treatment responders
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-responders (control group)
Number of subjects: 105
Study: 20196067

Group type: EXPERIMENTAL
Intervention: Prostate cancer screening
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Contamination adjusted prostate cancer screening
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Noncompliance adjusted prostate cancer screening
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Fully adjusted prostate cancer screening
Number of subjects: 42376
Study: 17323135

Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation (500 microg daily)
Number of subjects: 9
Study: 15334317

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (Rb) 400 mg twice a day, tetracycline (T) 1 g twice a day, metronidazole (M) 500 mg three times a day for 14 days (RbTM)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ranitidine bismuth citrate (Rb) 400 mg twice a day for 14 days and azithromycin (A) 500 mg once a day for 7 days (RbA)
Number of subjects: 52
Study: 11261502

Group type: EXPERIMENTAL
Intervention: 20 mg glatiramer acetate (GA)
Number of subjects: 239
Study: 9820378

Group type: EXPERIMENTAL
Intervention: Intraduodenal feeding
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intragastric feeding
Number of subjects: 6
Study: 8087328

Group type: EXPERIMENTAL
Intervention: ICI 204,219 40 mg
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study: 2666019

Group type: EXPERIMENTAL
Intervention: Cycloprovera (medroxyprogesterone acetate 25 mg + estradiol cypionate 5 mg)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: HRP-102 (norethisterone enanthate 50 mg + estradiol valerate 5 mg)
Number of subjects: 130
Study: 140037

Group type: EXPERIMENTAL
Intervention: Minoxidil in combination with frusemide and propranolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hydrallazine in combination with frusemide and propranolol
Number of subjects: 30
Study: 31829481

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) training (2×/week)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nutritional support (Control group)
Number of subjects: 80
Study: 31511291

Group type: EXPERIMENTAL
Intervention: Informed health choices (IHC) resources
Number of subjects: 85
Study: 28409242

Group type: EXPERIMENTAL
Intervention: Topical ropivacaine with 20 mg ketamine (RK group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Topical ropivacaine with saline (RS group)
Number of subjects: 66
Study: 25549910

Group type: EXPERIMENTAL
Intervention: Brief self-regulatory intervention
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 166
Study: 24398192

Group type: EXPERIMENTAL
Intervention: Direct Optical Entry (DOE)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Open Hasson Technique (OHT)
Number of subjects: 224
Study: 20694567

Group type: EXPERIMENTAL
Intervention: Ultrasonic vibration (V) with G-Cem (GC)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Static seating pressure (P) with G-Cem (GC)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ultrasonic vibration (V) with Gradia Forte (GA)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Static seating pressure (P) with Gradia Forte (GA)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ultrasonic vibration (V) with RelyX Unicem (RUC)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Static seating pressure (P) with RelyX Unicem (RUC)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ultrasonic vibration (V) with RelyX Unicem Aplicap (RUA)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Static seating pressure (P) with RelyX Unicem Aplicap (RUA)
Number of subjects: 56
Study: 19327753

Group type: EXPERIMENTAL
Intervention: Suppression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focused distraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acceptance
Number of subjects: 0
Study: 15583076

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 9193
Study: 12082670

Group type: EXPERIMENTAL
Intervention: Female Sexual Distress Scale (FSDS)
Number of subjects: 500
Study: 9973019

Group type: EXPERIMENTAL
Intervention: Iomeprol (nonionic)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Ioxaglate (ionic)
Number of subjects: 2000